Pay in 4 interest-free payments of $7.06 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Tirzepatide starts at 2.5 mg weekly (Mounjaro), increasing by 2.5 mg every 4 weeks until the desired maintenance dose (up to 15 mg ) is reached
Brown, Patients with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasias should not take Zepbound. Additionally, patients with pancreatitis, severe gastrointestinal disease, kidney disease, gallbladder disease, or cirrhosis should discuss the risks of taking Zepbound with their healthcare provider
An error at any step cascades through the rest
.png?sfvrsn=f94c669f_5)
This can reduce side effects and medication costs
US$ 25.97
US$ 24.67
US$ 29.11
US$ 28.23
US$ 27.77
US$ 26.87
US$ 22.34
US$ 25.23
